Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration

Sobolewska B, Sabsabi M, Ziemssen F

Clinical Ophthalmology 2021, 15:4317-4326

Published Date: 27 October 2021